A Letter from Our CEO

July 1, 2024

Navigating the Challenges of Launching a New Drug with RareMed Solutions

May 28, 2024

A Letter to Our Partners

May 2, 2024

Autoimmune Disease Awareness Month

April 1, 2024

RareMed Solutions voted #1 in Patient Satisfaction in the US

March 18, 2024

Rare Disease Day 2024

February 29, 2024
hub pharmacy, hub services, hub services providers, hub specialty pharmacy, market access strategy, non commercial pharmacy, oncology patient support programs, patient access services, patient hub services, patient services, patient support, patient support program, patient support services, pharma commercialization, pharma hub services, pharma hub services providers, pharma product launch, pharmacy hub pharmacy hub services, specialty pharmacy hub services, RarePath, RarePath Connect, Rare Fellowship

RareMed Pharmacy Fellowship – RareMed’s Transformative Learning Experience

February 23, 2024

2023 Year in Review

January 5, 2024
Raremed Solution

RareMed Recognized in Pittsburgh Technology Council Tech 50 Awards as Innovator of the Year

November 30, 2023

RareMed Solutions Earns Tech 50 Award from Pittsburgh Technology Council; CEO Dr. Gordon Vanscoy Finalist for CEO of the Year

October 11, 2023
hub pharmacy, hub services, hub services providers, hub specialty pharmacy, market access strategy, non commercial pharmacy, oncology patient support programs, patient access services, patient hub services, patient services, patient support, patient support program, patient support services, pharma commercialization, pharma hub services, pharma hub services providers, pharma product launch, pharmacy hub pharmacy hub services, specialty pharmacy hub services, RarePath, RarePath Connect

RareMed Consistently Leading the Way with Top-Ranking Net Promotor Scores (90+)

October 5, 2023

RareMed Recognized as Top Workplace by Pittsburgh Post-Gazette for Fourth Consecutive Year

September 12, 2023